BioLineRx (BLRX) will change the number of ordinary shares represented by American depositary shares to 600 shares per ADS from 15.
The change in the exchange ratio will have the same effect as a 1-for-40 reverse stock split of the ADSs, lowering the number of outstanding ADSs to 3.56 million from 142.3 million, the company said Friday in a statement.
The new ratio will take effect before the start of trading on the Nasdaq on Thursday.
Price: 0.10, Change: -0.02, Percent Change: -17.80
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。